Adalimumab induced psoriasis during the treatment of inflammatory bowel disease - case report

Introduction. Anti-tumor necrosis factor α (anti-TNF-α) antibodies are used to treat immune-mediated inflammatory diseases (IMID), which include inflammatory bowel diseases or psoriasis. In the group of adverse events induced by anti-TNF agents we can observe psoriatic lesions. Case report . We pres...

Full description

Saved in:
Bibliographic Details
Main Authors: Edyta Lelonek (Author), Magdalena Dębicka (Author), Joanna Maj (Author), Anita Hryncewicz-Gwóźdź (Author), Łukasz Matusiak (Author)
Format: Book
Published: Termedia Publishing House, 2015-09-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available